A phase III randomized study of intensive cisplatin with or without amifostine in patients with non-small cell lung cancer (NSCLC)

Autor:	B Kasimis, U. Gatzemeier, H. Macha, Joan H. Schiller, J. von Pawel, A Arcenas, W Tester
Rok vydání:	2000
Předmět:	Pulmonary and Respiratory Medicine Oncology Cisplatin Cancer Research medicine.medical_specialty business.industry non-small cell lung cancer (NSCLC) Amifostine medicine.disease law.invention Randomized controlled trial law Internal medicine medicine In patient business medicine.drug
Zdroj:	Lung Cancer. 29:27-28
ISSN:	0169-5002
DOI:	10.1016/s0169-5002(00)80086-0
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::5460d57437c58ebfe995f28f12de5b32 https://doi.org/10.1016/s0169-5002(00)80086-0 Zobrazit plný text záznamu Full Text from ScienceDirect